In vitro diagnostic assay measuring HE4 and CA125 biomarkers for evaluation of endometrial-like cancer lymph node metastasis. This combined marker approach provides improved diagnostic accuracy for gynecological malignancies.
Manufactured by
China
CanAg Diagnostics (Fujirebio) is a global leader in in-vitro diagnostics and the world's largest manufacturer of tumor marker gold standards. The company provides detection products for most common solid tumors including gastrointestinal, squamous cell, liver, pancreatic, prostate, ovarian, skin, and lung cancers. All products are manufactured in ISO13485-certified facilities in Sweden and USA, supplying tumor marker antigens and antibodies to major international diagnostic manufacturers.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Anbio Biotechnology Limited
Germany · 3 relevant products
Burning Rock Dx Co. Ltd.
China · 1 relevant product
Qassay
United States · 1 relevant product
Atila BioSystems
United States · 1 relevant product
Deaou Gene Technology Co.,Ltd
China · 1 relevant product
Attogen Biomedical(Suzhou)Ltd.Inc
China · 6 relevant products
GESIM Gesellschaft für Silizium-Mikrosysteme mbH
Germany · 1 relevant product
Zhejiang Pushkang Biotechnology Co., Ltd.
China · 2 relevant products
Biopsense Oy
Finland · 1 relevant product
Beijing Hotgen Biotech Co.,Ltd
China · 1 relevant product
56 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 103 closest product alternatives
Anbio Biotechnology Limited · Germany
Comprehensive testing suite for oncology biomarkers including CEA, AFP, and CA markers. Supports cancer diagnosis, prognosis, and treatment monitoring.
Burning Rock Dx Co. Ltd. · China
Multiplex immunoassay platform for detecting circulating cancer biomarkers in blood samples. Facilitates early diagnosis and treatment response monitoring in oncology patients.
Qassay · United States
Assay for detecting and quantifying cancer-related biomarkers. Supports early detection and monitoring through rapid point-of-care testing.
Atila BioSystems · United States
A molecular assay designed for cervical cancer screening applications utilizing Atila BioSystems nucleic acid amplification chemistry.
Deaou Gene Technology Co.,Ltd · China
Molecular diagnostic assay for detecting and genotyping high-risk human papillomavirus strains. Supports cervical cancer screening and risk stratification.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Comprehensive cervical cytology detection system for screening intraepithelial neoplasia. Combines immunochemical techniques with molecular markers for cervical disease identification. Designed for routine gynecological screening applications.
GESIM Gesellschaft für Silizium-Mikrosysteme mbH · Germany
Multiplexed microarray assay for simultaneous detection of multiple tumor markers in clinical samples. Enables comprehensive cancer biomarker profiling in a single test.
Zhejiang Pushkang Biotechnology Co., Ltd. · China
Comprehensive chemiluminescent immunoassay panel for reproductive, metabolic, and adrenal hormone measurement. Compatible with automated immunomagnetic analyzer systems.
Attogen Biomedical(Suzhou)Ltd.Inc · China
Proprietary E7 antibody-based immunocytochemistry assay for cervical intraepithelial neoplasia detection. Enables immunochemical staining and identification of tissue samples using monoclonal antibody markers. Designed for cervical screening and tissue characterization.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
Beijing Hotgen Biotech Co.,Ltd · China
ELISA-based diagnostic kit for tumor marker detection and quantification. Supports cancer screening and monitoring in laboratory settings.
Sclavo Diagnostics International S.p.A. · Italy
Immunochemical systems for measurement of tumor-associated antigens including PSA, CEA, and AFP. Applied in cancer screening and monitoring applications.
91 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products